Abstract
The newer agents of the platelet ADP-receptor blocking class of antiplatelet drugs have greater antiplatelet efficacy and are less prone to cytochrome P450-related drug interactions than clopidogrel but are associated with an increased risk of haemorrhagic complications.
| Original language | English |
|---|---|
| Pages (from-to) | 65-70 |
| Number of pages | 6 |
| Journal | Medicine Today |
| Volume | 11 |
| Issue number | 8 |
| Publication status | Published - Aug 2010 |